SCHEMBL24146014

SCHEMBL24146014

Cc1cccc(C)c1C(O)N(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CYP2A6 P11509 2/20 0.36
CYP1A2 P05177 1/20 0.36
TRPA1 O75762 2/20 0.36
ATM Q13315 1/20 0.36
TSHR P16473 2/20 0.35
ACHE P22303 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MAPT P10636 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
GAA P10253 1/20 0.32
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
CD44 P16070 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8932197 0.74 ALDH1A1 (0.48) ALDH1A1CA1CA2CA7CA9
SCHEMBL28050755 0.74 ALDH1A1 (0.48) ALDH1A1CA1CA2CA7CA9
SCHEMBL24146289 0.73 GABRA1 (0.31) ALDH1A1KDM4EGABRA1
SCHEMBL578005 0.72 CA1 (0.46) ALDH1A1CA1CA2CA7CA9
SCHEMBL30514705 0.70 CA1 (0.39) ALDH1A1CA1CA2CA7CA9
SCHEMBL21873585 0.69 CA1 (0.48) ALDH1A1CA1CA2CA7CA9
SCHEMBL12238610 0.68 CA1 (0.42) ALDH1A1CA1CA2CA7CA9
Bromide SCHEMBL21466187 0.68 CA1 (0.37) ALDH1A1CA1CA2CA7CA9
SCHEMBL12140926 0.67 AOC3 (0.45) ALDH1A1ACHEKDM4ESLC6A2SLC6A4
SCHEMBL24186190 0.66 HTT (0.42) CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691938-B2 Process for preparing 2,6-dialkylphenylacetic acids BAYER AKTIENGESELLSCHAFT (DE) 2023-07-04 US disclosed
US-11691938-B2 Process for preparing 2,6-dialkylphenylacetic acids BAYER AKTIENGESELLSCHAFT (DE) 2023-07-04 US disclosed
US-20210403406-A1 PROCESS FOR PREPARING 2,6-DIALKYLPHENYLACETIC ACIDS BAYER AKTIENGESELLSCHAFT (DE) 2021-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210403406-A1 PROCESS FOR PREPARING 2,6-DIALKYLPHENYLACETIC ACIDS ADH1C, ADH1A, ADH5 ALDH1A1 51/4885CA1 114/4885CA2 12/4885
US-11691938-B2 Process for preparing 2,6-dialkylphenylacetic acids ADH1C, ADH1A, ADH5 ALDH1A1 51/4885CA1 114/4885CA2 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.